{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:56:16Z","timestamp":1793350576093,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jns.2020.116719","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:06:45Z","timestamp":1580429205000},"page":"116719","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Infectious diseases occurring in the context of substance use disorders: A concise review"],"prefix":"10.1016","volume":"411","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6627-2410","authenticated-orcid":false,"given":"Bhanu Prakash","family":"Kolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Oesterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick","family":"Southwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Rummans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.116719_bb0005","series-title":"NSDUH Annual National Report. Substance Abuse and Mental Health Services Administration","volume":"2019","author":"Substance Abuse and Mental Health Services Administration","year":"2018"},{"key":"10.1016\/j.jns.2020.116719_bb0010","author":"World Health Organization"},{"key":"10.1016\/j.jns.2020.116719_bb0015","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jns.2020.116719_bb0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: no easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jns.2020.116719_bb0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.jns.2020.116719_bb0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.15585\/mmwr.mm6503a2","article-title":"Increases in acute hepatitis B virus infections - kentucky, tennessee, and West Virginia, 2006\u20132013","volume":"65","author":"Harris","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.jns.2020.116719_bb0035","series-title":"Estimated HIV Incidence and Prevalence in the United States, 2010\u20132016","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"10.1016\/j.jns.2020.116719_bb0040","doi-asserted-by":"crossref","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","article-title":"Notes from the field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015\u20132018","volume":"68","author":"Cranston","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.jns.2020.116719_bb0045","doi-asserted-by":"crossref","first-page":"344","DOI":"10.15585\/mmwr.mm6815a2","article-title":"Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs \u2014 Seattle, Washington, 2018","volume":"68","author":"Golden","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.jns.2020.116719_bb0050","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/QAI.0b013e3181f9c0b6","article-title":"Infectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosis","volume":"55","author":"Friedland","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jns.2020.116719_bb0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.15288\/jsad.2008.69.924","article-title":"Drug users seeking emergency care for soft tissue infection at high risk for subsequent hospitalization and death","volume":"69","author":"Binswanger","year":"2008","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.jns.2020.116719_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129360","article-title":"Cost analysis of hospitalizations for infections related to injection drug use at a county safety-net hospital in Miami, Florida","volume":"10","author":"Tookes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2020.116719_bb0065","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11481-011-9292-5","article-title":"Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections","volume":"6","author":"Roy","year":"2011","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jns.2020.116719_bb0070","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3565(25)39466-8","article-title":"Suppression of peritoneal macrophage phagocytosis of Candida albicans by opioids","volume":"267","author":"Szabo","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jns.2020.116719_bb0075","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-5728(95)00159-X","article-title":"Inhibition of primary murine macrophage cytokine production in vitro following treatment with the kappa-opioid agonist U50,488H","volume":"64","author":"Alicea","year":"1996","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jns.2020.116719_bb0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.188.2.317","article-title":"Opiates transdeactivate chemokine receptors: \u03b4 and \u03bc opiate receptor\u2013mediated heterologous desensitization","volume":"188","author":"Grimm","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jns.2020.116719_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11481-015-9615-z","article-title":"Turning over a new leaf: cannabinoid and endocannabinoid modulation of immune function","volume":"10","author":"Cabral","year":"2015","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.jns.2020.116719_bb0090","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.pnpbp.2015.09.001","article-title":"Opposing effects of alcohol on the immune system","volume":"65","author":"Barr","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jns.2020.116719_bb0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s15010-004-3106-0","article-title":"Staphylococcus aureus infections in injection drug users: risk factors and prevention strategies","volume":"32","author":"Bassetti","year":"2004","journal-title":"Infection"},{"key":"10.1016\/j.jns.2020.116719_bb0100","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3109\/10826080009148220","article-title":"Survival of HIV-1 in syringes: effects of temperature during storage","volume":"35","author":"Abdala","year":"2000","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.jns.2020.116719_bb0105","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0140-6736(84)91854-3","article-title":"Risk of contracting hepatitis B from discarded syringes","volume":"1","author":"Cocchi","year":"1984","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jns.2020.116719_bb0110","article-title":"Survival of hepatitis C virus in syringes is dependent on the design of the syringe-needle and dead space Volume","volume":"10","author":"Binka","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2020.116719_bb0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugpo.2005.02.005","article-title":"Interventions to reduce the sexual risk behaviour of injecting drug users","volume":"16","author":"Jarlais","year":"2005","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jns.2020.116719_bb0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.childyouth.2015.03.005","article-title":"Risky sexual behavior and substance use among adolescents: a meta-analysis","volume":"52","author":"Ritchwood","year":"2015","journal-title":"Child Youth Serv. Rev."},{"key":"10.1016\/j.jns.2020.116719_bb0125","first-page":"311","article-title":"The natural history of HIV infection","volume":"8","author":"Sabin","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jns.2020.116719_bb0130","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11524-005-9009-2","article-title":"Update and overview of practical epidemiologic aspects of HIV\/AIDS among injection drug users in the United States","volume":"83","author":"Santibanez","year":"2006","journal-title":"J. Urban Health"},{"key":"10.1016\/j.jns.2020.116719_bb0135","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa1515195","article-title":"HIV infection linked to injection use of oxymorphone in Indiana, 2014\u20132015","volume":"375","author":"Peters","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.116719_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30176-0","article-title":"Dynamics of the HIV outbreak and response in Scott County, IN, USA, 2011\u201315: a modeling study","volume":"5","author":"Gonsalves","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jns.2020.116719_bb0145","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/OLQ.0000000000000719","article-title":"Selecting an HIV test: a narrative review for clinicians and researchers","volume":"44","author":"Hurt","year":"2017","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0150","series-title":"Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection","year":"2016"},{"key":"10.1016\/j.jns.2020.116719_bb0155","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomized, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jns.2020.116719_bb0160","article-title":"Recent advances in pre-exposure prophylaxis for HIV","volume":"359","author":"Desai","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2020.116719_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3018(18)30132-2","article-title":"Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study","volume":"5","author":"Bavinton","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jns.2020.116719_bb0170","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.pop.2017.07.005","volume":"44","author":"Thuener","year":"2017","journal-title":"Primary Care"},{"key":"10.1016\/j.jns.2020.116719_bb0175","first-page":"82","article-title":"Hepatitis A virus infections in injecting drug users","volume":"6","author":"Crowcroft","year":"2003","journal-title":"Commun. Dis. Public Health"},{"key":"10.1016\/j.jns.2020.116719_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3389\/fpsyt.2011.00079","article-title":"Hepatitis A virus among drug users and the role of vaccination: a review","volume":"2","author":"Lugoboni","year":"2012","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jns.2020.116719_bb0185","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jns.2020.116719_bb0190","series-title":"Hepatitis A Vaccines. Releve Epidemiologique Hebdomadaire","first-page":"38","volume":"75","year":"2000"},{"key":"10.1016\/j.jns.2020.116719_bb0195","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1086\/339192","article-title":"Incidence and risk factors for acute hepatitis B in the United States, 1982\u20131998: implications for vaccination programs","volume":"185","author":"Goldstein","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0200","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.jns.2020.116719_bb0205","series-title":"Global Hepatitis Report 2017","year":"2017"},{"key":"10.1016\/j.jns.2020.116719_bb0210","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jns.2020.116719_bb0215","first-page":"314","article-title":"Hepatitis B: Screening, prevention, diagnosis, and treatment","volume":"99","author":"Wilkins","year":"2019","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.jns.2020.116719_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(17)30375-3","article-title":"Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review","volume":"5","author":"Degenhardt","year":"2017","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.jns.2020.116719_bb0225","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/aje\/kwn237","article-title":"Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place","volume":"168","author":"Hagan","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jns.2020.116719_bb0230","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/oxfordjournals.epirev.a017921","article-title":"Transmission of hepatitis C virus: rates, routes, and cofactors","volume":"18","author":"MacDonald","year":"1996","journal-title":"Epidemiol. Rev."},{"issue":"4","key":"10.1016\/j.jns.2020.116719_bb0235","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.2019.5353","article-title":"Management of hepatitis C in 2019management of hepatitis C in 2019management of hepatitis C in 2019","volume":"322","author":"Marks","year":"2019","journal-title":"JAMA"},{"issue":"Suppl. 2","key":"10.1016\/j.jns.2020.116719_bb0240","article-title":"Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?","volume":"21","author":"Martin","year":"2018","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.jns.2020.116719_bb0245","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/heart.89.5.577","article-title":"Injection drug use and right sided endocarditis","volume":"89","author":"Moss","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.jns.2020.116719_bb0250","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1093\/clinids\/8.3.374","article-title":"Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: a prospective comparative study","volume":"8","author":"Levine","year":"1986","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0255","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMra042823","article-title":"Bacterial infections in drug users","volume":"353","author":"Gordon","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.116719_bb0260","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1001\/jamainternmed.2014.2556","article-title":"Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial","volume":"174","author":"Liebschutz","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jns.2020.116719_bb0265","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/313703","article-title":"High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco","volume":"30","author":"Binswanger","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0270","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/clinids\/8.6.904","article-title":"Bone and joint infections in intravenous drug abusers","volume":"8","author":"Chandrasekar","year":"1986","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0275","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0891-5520(02)00016-8","article-title":"Bone and joint infections in injection drug users","volume":"16","author":"Kak","year":"2002","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.jns.2020.116719_bb0280","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/clinids\/23.1.107","article-title":"Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects","volume":"23","author":"Boschini","year":"1996","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0285","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archinternmed.2008.535","article-title":"Tuberculosis and substance abuse in the United States, 1997\u20132006","volume":"169","author":"Oeltmann","year":"2009","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jns.2020.116719_bb0290","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599,912 current drinkers in 83 prospective studies","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jns.2020.116719_bb0295","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(15)00151-8","article-title":"Tuberculosis","volume":"387","author":"Dheda","year":"2016","journal-title":"Lancet (Lond. Engl.)"},{"key":"10.1016\/j.jns.2020.116719_bb0300","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/bjo.2006.0108365","article-title":"Lemon juice and Candida endophthalmitis in crack-cocaine misuse","volume":"91","author":"Albini","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jns.2020.116719_bb0305","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/340053","article-title":"Malaria in injection drug abusers in Vietnam","volume":"34","author":"Chau","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0310","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0035-9203(86)90136-7","article-title":"An outbreak of Plasmodium vivax malaria among heroin users in Spain","volume":"80","author":"Gonzalez Garcia","year":"1986","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.jns.2020.116719_bb0315","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe Programmes in people who inject drugs - An overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jns.2020.116719_bb0320","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-017-0178-6","article-title":"Harm reduction in the USA: the research perspective and an archive to David Purchase","volume":"14","author":"Des Jarlais","year":"2017","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.jns.2020.116719_bb0325","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.vaccine.2005.12.045","article-title":"Hepatitis vaccination among drug users","volume":"24","author":"Quaglio","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jns.2020.116719_bb0330","first-page":"1","article-title":"Recommendations of the advisory council for the elimination of tuberculosis (ACET)","volume":"47","author":"Development of new vaccines for tuberculosis","year":"1998","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.jns.2020.116719_bb0335","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/ciw416","article-title":"Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis","volume":"63","author":"Low","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jns.2020.116719_bb0340","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jns.2020.116719_bb0345","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jsat.2007.08.004","article-title":"Buprenorphine\/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors","volume":"35","author":"Sullivan","year":"2008","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.jns.2020.116719_bb0350","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.drugpo.2014.01.009","article-title":"WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs","volume":"25","author":"Walsh","year":"2014","journal-title":"Int. J. Drug Policy"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20300551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20300551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:50:29Z","timestamp":1758383429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20300551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":70,"alternative-id":["S0022510X20300551"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.116719","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infectious diseases occurring in the context of substance use disorders: A concise review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.116719","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116719"}}